Pierre Lefesvre

660 total citations
20 papers, 404 citations indexed

About

Pierre Lefesvre is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pierre Lefesvre has authored 20 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pierre Lefesvre's work include Viral Infectious Diseases and Gene Expression in Insects (4 papers), Virus-based gene therapy research (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Pierre Lefesvre is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (4 papers), Virus-based gene therapy research (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Pierre Lefesvre collaborates with scholars based in Belgium, Netherlands and United Kingdom. Pierre Lefesvre's co-authors include Fabrice Barlési, Mariëlle I. Gallegos-Ruiz, José Antonio Rodríguez, Giuseppe Giaccone, Simone W. Span, Anderson Loundou, Frank A.E. Kruyt, Joline Attema, Ilse Rooman and Andrew V. Biankin and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and British Journal of Cancer.

In The Last Decade

Pierre Lefesvre

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Lefesvre Belgium 8 283 111 63 62 51 20 404
Robyn T. Sussman United States 11 331 1.2× 160 1.4× 106 1.7× 44 0.7× 61 1.2× 24 468
Zhijun Du United States 11 249 0.9× 218 2.0× 76 1.2× 77 1.2× 29 0.6× 16 393
Helena Antoniadis Switzerland 7 235 0.8× 128 1.2× 64 1.0× 63 1.0× 21 0.4× 8 350
Anthony G. Clementz United States 8 321 1.1× 220 2.0× 84 1.3× 25 0.4× 68 1.3× 9 497
Kazunobu Isogaya Japan 12 427 1.5× 180 1.6× 98 1.6× 28 0.5× 59 1.2× 15 533
Wen-Ren Wu Taiwan 9 170 0.6× 90 0.8× 125 2.0× 38 0.6× 96 1.9× 10 333
Fumitake Kai Japan 10 220 0.8× 231 2.1× 100 1.6× 27 0.4× 117 2.3× 19 436
Charles P. Xavier United States 8 292 1.0× 71 0.6× 55 0.9× 40 0.6× 69 1.4× 12 396
Steffen Heeg Germany 11 273 1.0× 240 2.2× 87 1.4× 32 0.5× 60 1.2× 26 509
A P Kyritsis United States 9 269 1.0× 160 1.4× 96 1.5× 39 0.6× 38 0.7× 11 394

Countries citing papers authored by Pierre Lefesvre

Since Specialization
Citations

This map shows the geographic impact of Pierre Lefesvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Lefesvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Lefesvre more than expected).

Fields of papers citing papers by Pierre Lefesvre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Lefesvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Lefesvre. The network helps show where Pierre Lefesvre may publish in the future.

Co-authorship network of co-authors of Pierre Lefesvre

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Lefesvre. A scholar is included among the top collaborators of Pierre Lefesvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Lefesvre. Pierre Lefesvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefesvre, Pierre, et al.. (2024). The challenges in lymphogranuloma venereum diagnosis whether NAAT is negative, a case series. International Journal of STD & AIDS. 36(4). 283–288.
2.
Smet, Vincent De, Nathalie Eysackers, Ayla Smout, et al.. (2024). Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease. JHEP Reports. 6(5). 101036–101036. 3 indexed citations
4.
Leclercq, Philippe, et al.. (2024). Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge. Acta Oncologica. 63. 192–197.
5.
Olsen, Catharina, et al.. (2023). Heterotopia of salivary gland tissue in the pancreas. Diagnostic Pathology. 18(1). 98–98. 2 indexed citations
6.
Messaoudi, Nouredin, Rastislav Kunda, Philippe Giron, et al.. (2023). High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer. The Journal of Pathology. 262(1). 76–89. 4 indexed citations
7.
Debackere, Koen, Lukas Marcelis, Nicolas Dierckxsens, et al.. (2022). Primary mediastinal large B‐cell lymphoma is characterized by large‐scale copy‐neutral loss of heterozygosity. Genes Chromosomes and Cancer. 61(10). 603–615. 3 indexed citations
8.
Grève, Jacques De, et al.. (2022). Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report. Diagnostics. 12(2). 249–249. 5 indexed citations
9.
Moretti, Marco, Pierre Lefesvre, & Joop Jonckheer. (2021). Cirrhosis and partial portal thrombosis leading to severe variceal bleeding, an unusual presentation of sarcoidosis. Acta Clinica Belgica. 77(4). 767–771. 2 indexed citations
10.
Lefesvre, Pierre, Rémy Nicolle, Andrew V. Biankin, et al.. (2019). Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications. Annals of Oncology. 30(9). 1428–1436. 42 indexed citations
11.
Schallier, Denis, et al.. (2016). Effective Treatment of Pleural Epitheloid Hemangio-endothelioma with Pazopanib: A Case Report.. PubMed. 36(1). 351–4. 3 indexed citations
12.
Carrasco, Javier, Pierre Lefesvre, Catherine Hubert, et al.. (2015). Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone. British Journal of Cancer. 113(9). 1298–1304. 15 indexed citations
13.
Lederer, Damien, Brian T. Wilson, Pierre Lefesvre, et al.. (2012). Atypical findings in three patients with Pai syndrome and literature review. American Journal of Medical Genetics Part A. 158A(11). 2899–2904. 14 indexed citations
14.
Beeker, Aart, Epie Boven, Pierre Lefesvre, Richard P. Golding, & Cees J. van Groeningen. (2008). Retroperitoneal mature teratoma after orchidectomy for a stage IB pure embryonal testicular carcinoma. International Journal of Clinical Oncology. 13(1). 71–73. 2 indexed citations
15.
Barlési, Fabrice, Giuseppe Giaccone, Mariëlle I. Gallegos-Ruiz, et al.. (2007). Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(28). 4358–4364. 209 indexed citations
16.
Gonçalves, Manuel A.F.V., Gijsbert P. van Nierop, Marloes R. Tijssen, et al.. (2005). Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration Ability. Journal of Virology. 79(5). 3146–3162. 32 indexed citations
17.
Lefesvre, Pierre, et al.. (2003). Genetic heterogeneity in response to adenovirus gene therapy. BMC Molecular Biology. 4(1). 4–4. 13 indexed citations
18.
Lefesvre, Pierre, et al.. (2003). Pharmacogenetic heterogeneity of transgene expression in muscle and tumours. BMC Pharmacology. 3(1). 11–11. 5 indexed citations
19.
Lefesvre, Pierre, et al.. (2002). A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Molecular Biology. 3(1). 12–12. 41 indexed citations
20.
Lefesvre, Pierre, et al.. (2002). Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth. BMC Cancer. 2(1). 17–17. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026